secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEPHROS INC (NEPH)
CIK:        0001196298
Form:       8-K
Filed at:   2023-08-09T23:59:59+00:00
Accession:  0001493152-23-027357
Event type: earnings
Sentiment:  positive
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nephros Q2 2023 revenue $3.5M (+24% YoY); net loss narrows to $0.4M
-------------------------------------------------------------------

- Net revenue $3.5M, up 24% from $2.9M in Q2 2022.
- Net loss from continuing ops narrowed to $0.4M from $0.7M; adjusted EBITDA loss $0.2M vs $0.4M.
- Gross margins improved to 59% from 49%; active customer sites up 6% to 1,427.
- Cash and equivalents $4.1M as of June 30, 2023; maintained positive cash flow.
- Cost of goods sold flat at $1.5M; SG&A increased to $2.2M from $1.9M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1196298/000149315223027357/0001493152-23-027357-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1196298/000149315223027357/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-027357

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer